실버니아 플래티넘(SLP)는 NASDAQ에 상장된 Healthcare · Health Information Services 기업입니다. 현재가 $18.44 (+0.05%), 시가총액 $0.30B, 52주 최저~최고 $11.36 ~ $34.35.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, E
실버니아 플래티넘의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
실버니아 플래티넘의 현재 주가는 $18.44 (+0.05%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
실버니아 플래티넘의 시가총액은 약 $0.30B입니다.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based